Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
Want to see IN:AJANTPHARM full AI Analyst Report?
Total Valuation
Ajanta Pharma Limited has a market cap or net worth of ₹388.04B. The enterprise value is ₹389.79B.
Market Cap₹388.04B
Enterprise Value₹389.79B
Share Statistics
Ajanta Pharma Limited has 124,935,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding124,935,620
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajanta Pharma Limited’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 20.47%.
Return on Equity (ROE)0.23
Return on Assets (ROA)0.17
Return on Invested Capital (ROIC)20.47%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee6.75M
Profits Per Employee1.31M
Employee Count8,073
Asset Turnover0.89
Inventory Turnover2.82
Valuation Ratios
The current PE Ratio of Ajanta Pharma Limited is 32.8. Ajanta Pharma Limited’s PEG ratio is 2.23.
PE Ratio32.8
PS Ratio6.43
PB Ratio7.74
Price to Fair Value7.74
Price to FCF231.72
Price to Operating Cash Flow135.57
PEG Ratio2.23
Income Statement
In the last 12 months, Ajanta Pharma Limited had revenue of 54.53B and earned 10.56B in profits. Earnings per share was 84.53.
Revenue54.53B
Gross Profit28.05B
Operating Income13.25B
Pretax Income13.78B
Net Income10.56B
EBITDA14.98B
Earnings Per Share (EPS)84.53
Cash Flow
In the last 12 months, operating cash flow was 2.84B and capital expenditures -1.73B, giving a free cash flow of 1.10B billion.
Operating Cash Flow2.84B
Free Cash Flow1.10B
Free Cash Flow per Share8.84
Dividends & Yields
Ajanta Pharma Limited pays an annual dividend of ₹28, resulting in a dividend yield of 1.04%
Dividend Per Share₹28
Dividend Yield1.04%
Payout Ratio35.98%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.36
52-Week Price Change20.31%
50-Day Moving Average2.94K
200-Day Moving Average2.71K
Relative Strength Index (RSI)54.07
Average Volume (3m)2.10K
Important Dates
Ajanta Pharma Limited upcoming earnings date is Jul 23, 2026, TBA (Confirmed).
Last Earnings DateMay 5, 2026
Next Earnings DateJul 23, 2026
Ex-Dividend Date―
Financial Position
Ajanta Pharma Limited as a current ratio of 2.64, with Debt / Equity ratio of 5.75%
Current Ratio2.64
Quick Ratio1.98
Debt to Market Cap<0.01
Net Debt to EBITDA0.10
Interest Coverage Ratio82.23
Taxes
In the past 12 months, Ajanta Pharma Limited has paid 3.22B in taxes.
Income Tax3.22B
Effective Tax Rate0.23
Enterprise Valuation
Ajanta Pharma Limited EV to EBITDA ratio is 23.50, with an EV/FCF ratio of 232.75.
EV to Sales6.46
EV to EBITDA23.50
EV to Free Cash Flow232.75
EV to Operating Cash Flow68.16
Balance Sheet
Ajanta Pharma Limited has ₹9.40B in cash and marketable securities with ₹2.46B in debt, giving a net cash position of ₹6.94B billion.
Cash & Marketable Securities₹9.40B
Total Debt₹2.46B
Net Cash₹6.94B
Net Cash Per Share₹55.56
Tangible Book Value Per Share₹359.05
Margins
Gross margin is 71.69%, with operating margin of 24.29%, and net profit margin of 19.37%.
Gross Margin71.69%
Operating Margin24.29%
Pretax Margin25.26%
Net Profit Margin19.37%
EBITDA Margin27.47%
EBIT Margin24.29%
Analyst Forecast
The average price target for Ajanta Pharma Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast17.31%
EPS Growth Forecast14.93%